Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-22T22:16:04.548Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Infection After Septic Shock Among Intensive Care Unit Patients

Published online by Cambridge University Press:  02 January 2015

Caroline Landelle ,
Alain Lepape ,
Adrien Français ,
Eve Tognet ,
Hélène Thizy ,
Nicolas Voirin ,
Jean François Timsit ,
Guillaume Monneret  and
Philippe Vanhems
Caroline Landelle
Affiliation:
Service d'Hygiène, Epidémiologie et Prévention, Grenoble, France Hospices Civils de Lyon, and the Epidémiologie et de Santé Publique, Laboratoire de Biométrie et Biologie Evolutive, UMR5558, CNRS, Université Lyon 1, Université de Lyon, Grenoble, France
Alain Lepape
Affiliation:
Service de Réanimation Chirurgicale, Grenoble, France
Adrien Français
Affiliation:
Epidémiologie Pronostique des Cancers et Affections Graves, Inserm U823, Centre de Recherche Institut Albert Bonniot, Grenoble, France
Eve Tognet
Affiliation:
Service de Réanimation Médicale, Grenoble, France
Hélène Thizy
Affiliation:
Hôpital Edouard Herriot, and the Centre d'Investigation Clinique de Lyon, CIC201, Inserm, Hôpital Louis Pradel, Grenoble, France
Nicolas Voirin
Affiliation:
Service d'Hygiène, Epidémiologie et Prévention, Grenoble, France Hospices Civils de Lyon, and the Epidémiologie et de Santé Publique, Laboratoire de Biométrie et Biologie Evolutive, UMR5558, CNRS, Université Lyon 1, Université de Lyon, Grenoble, France
Jean François Timsit
Affiliation:
Lyon, and the Service de Réanimation Médicale, CHU de Grenoble, Grenoble, France Epidémiologie Pronostique des Cancers et Affections Graves, Inserm U823, Centre de Recherche Institut Albert Bonniot, Grenoble, France
Guillaume Monneret
Affiliation:
Centre Hospitalier de Lyon Sud, and the Laboratoire d'Immunologie, Grenoble, France
Philippe Vanhems*
Affiliation:
Service d'Hygiène, Epidémiologie et Prévention, Grenoble, France Hospices Civils de Lyon, and the Epidémiologie et de Santé Publique, Laboratoire de Biométrie et Biologie Evolutive, UMR5558, CNRS, Université Lyon 1, Université de Lyon, Grenoble, France
*
Service d'Hygiène, Epidémiologie et Prévention, Hôpital Edouard Herriot, Hospices Civils de Lyon, 5 Place d'Arsonval, Lyon F-69437, France ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives.

To measure the incidence of nosocomial infection (NI) among patients with septic shock according to the place of septic shock acquisition and to evaluate the increase in the risk of pulmonary infection associated with septic shock.

Design.

Prospective cohort study.

Setting.

TWO intensive care units (ICUs) of a French university hospital.

Patients and Methods.

The study included a total of 209 septic shock patients during the period December 1, 2001 through April 30, 2005. The place of septic shock acquisition for 108 patients was the community; for 87, the hospital; and for 14, the ICU. To evaluate the impact of septic shock on the development of pulmonary infection, a competitive and adjusted hazard ratio (aHR) model was applied to nontrauma ICU patients.

Results.

Among the 209 study patients, 48 (23%) experienced 66 NIs after septic shock. There was no significant difference in the NI attack rates according to place of acquisition: for the community acquisition group, 24 cases per 100 patients (95% confidence interval [CI], 16-32); for the hospital acquisition group, 20 cases per 100 patients (95% CI, 11-28); and for the ICU acquisition group, 36 cases per 100 patients (95% CI, 11-61) (P = .3). For nontrauma ICU patients, the presence of community-acquired septic shock was found to be independently associated with a higher incidence of pulmonary infection, compared with the absence of septic shock (aHR, 2.12 [95% CI, 1.08-4.16]; P = .03).

Conclusions.

The risk of NI did not differ by the place of septic shock acquisition. The risk of pulmonary infection was higher for ICU patients with community-acquired septic shock who were admitted for underlying nontrauma disease. Studies are needed to investigate the pathogenic mechanisms that facilitate pulmonary infection in this population, taking into account exposure to invasive devices and immunosuppression after the initial phase of septic shock.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 11 , November 2008 , pp. 1054 - 1065
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Annane, D, Aegerter, P, Jars-Guincestre, MC, Guidet, B, CUB-Réa Network. Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med 2003;168:165–172.CrossRefGoogle ScholarPubMed
2.Friedman, G, Silva, E, Vincent, JL. Has the mortality of septic shock changed with time? Crit Care Med 1998;26:2078–2086.CrossRefGoogle ScholarPubMed
3.Dellinger, RP, Carlet, JM, Masur, H, et al.Surviving sepsis: campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858–873.CrossRefGoogle ScholarPubMed
4.Vincent, JL. Nosocomial infections in adult intensive-care units. Lancet 2003;361:2068–2077.CrossRefGoogle ScholarPubMed
5.Hotchkiss, RS, Karl, IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138–150.CrossRefGoogle ScholarPubMed
6.Brawley, RL, Weber, DJ, Samsa, GP, Rutala, WA. Multiple nosocomial infections: an incidence study. Am J Epidemiol 1989;130:769–780.CrossRefGoogle ScholarPubMed
7.Alberti, C, Brun-Buisson, C, Burchardi, H, et al.Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002;28:108–121.CrossRefGoogle ScholarPubMed
8.Roman-Marchant, O, Orellana-Jimenez, CE, De Backer, D, Melot, C, Vincent, JL. Septic shock of early or late onset: does it matter? Chest 2004;126:173–178.CrossRefGoogle ScholarPubMed
9.Vanhems, P, Lepape, A, Savey, A, Jambou, P, Fabry, J. Nosocomial pulmonary infection by antimicrobial-resistant bacteria of patients hospitalized in intensive care units: risk factors and survival. J Hosp Infect 2000;45:98–106.Google Scholar
10.Monneret, G, Lepape, A, Voirin, N, et al.Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006;32:1175–1183.CrossRefGoogle ScholarPubMed
11.Bone, RC, Balk, RA, Cerra, FB, et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians / Society of Critical Care Medicine. Chest 1992;101:1644–1655.Google Scholar
12.Knaus, WA, Draper, EA, Wagner, DP, Zimmerman, JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–829.CrossRefGoogle ScholarPubMed
13.McCabe, WA, Jackson, GG. Gram negative bacteremia. Arch Intern Med 1962;110:847–855.CrossRefGoogle Scholar
14.Le Gall, JR, Lemeshow, S, Saulnier, F. A new Simplified Acute Physiology Score (SAPS II) based on a European / North American multicenter study. JAMA 1993;270:2957–2963.Google Scholar
15.Kumar, A, Roberts, D, Wood, KE, et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589–1596.CrossRefGoogle ScholarPubMed
16.Hospitals in Europe Link for Infection Control through Surveillance (HELICS). Surveillance of Nosocomial Infections in Intensive Care Units: Master Protocol. Lyon, France: Hospitals in Europe Link for Infection Control through Surveillance; 2004. Available at: http://helics.univ-lyonl.fr/helicshome.htm. Accessed January 24, 2008.Google Scholar
17.Estève, J, Benhamou, E, Raymond, L. Techniques for the analysis of cancer risk. In: Estève, J, Benhamou, E, Raymond, L, eds. Statistical Methods in Cancer Research IV: Descriptive Epidemiology. Lyon: IARC Scientific; 1994:89.Google ScholarPubMed
18.Kalbfleish, JD, Prentice, RL. Multivariate failure time data and competing risks. In: Kalbfleish, JD, Prentice, RL, eds. The Statistical Analysis of Failure Time Data. New York: Wiley; 1980:163–188.Google Scholar
19.Benichou, J, Gail, MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics 1990;46:813–826.CrossRefGoogle ScholarPubMed
20.Korn, EL, Dorey, FJ. Applications of crude incidence curves. Stat Med 1992;11:813–829.Google Scholar
21.Gray, RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics 1988;16:1141–1154.CrossRefGoogle Scholar
22.Alberti, C, Metivier, F, Landais, P, Thervet, E, Legendre, C, Chevret, S. Improving estimates of event incidence over time in populations exposed to other events: application to three large databases. J Clin Epidemiol 2003;56:536–545.CrossRefGoogle ScholarPubMed
23.Fine, J, Gray, RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496–509.CrossRefGoogle Scholar
24.R Development Core Team. R: a Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Available at: http://www.R-project.org/. Accessed January 24, 2008.Google Scholar
25.Leone, M, Bourgoin, A, Cambon, S, Dubuc, M, Albanese, J, Martin, C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003;31:462–467.CrossRefGoogle ScholarPubMed
26.Gooley, TA, Leisenring, W, Crowley, J, Storer, BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695–706.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
27.Pepe, MS, Mori, M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993;12:737–751.CrossRefGoogle ScholarPubMed
28.Rangel-Frausto, MS, Pittet, D, Costigan, M, Hwang, T, Davis, CS, Wenzel, RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995;273:117–123.CrossRefGoogle ScholarPubMed
29.Groupe Transversal Sepsis. Prise en charge initiale des états septiques graves de l'adulte et de l'enfant. France: Conférences d'experts; 2006.Google Scholar
30.Société Française d'Anesthésie et de Réanimation (SFAR). Prise en charge hémodynamique du sepsis sévère (nouveau-né exclu). France: Conférences de consensus organisées par la SFAR; 2005.Google Scholar
31.Société de Réanimation de Langue Française (SRLF). Corticothérapie au cours du choc septique et du SDRA. XXème conférence de consensus de la SRLF; 2000.Google Scholar
32.Société Française d'Anesthésie et de Réanimation (SFAR). Antibiothérapie probabiliste des états septiques graves. France: Conférence d'experts; 2004.Google Scholar